Farther Finance Advisors, LLC

Position in PRTA — Prothena Corp Public Ltd Co

CIK 1992825 SAN FRANCISCO, CA

Position in PRTA

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$24,357

-$2,217 QoQ

Shares Held

2,488

-9.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#134

of 187 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. PRTA ranks #75 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc.	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc.	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc.	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc	7,871	$450,378

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$24,357	2,488	-9.0%	Shares	Sole	2026-07-17
2026-03-31	$26,574	2,734	+12.3%	Shares	Sole	2026-04-07
2025-12-31	$23,244	2,434	0.0%	Shares	Sole	2026-01-23
2025-09-30	$23,755	2,434	-0.9%	Shares	Sole	2025-10-14
2025-06-30	$14,913	2,457	+154.1%	Shares	Sole	2025-07-11
2025-03-31	$11,966	967	+173.9%	Shares	Sole	2025-04-14
2024-12-31	$4,889	353	-5.9%	Shares	Sole	2025-02-10
2024-09-30	$6,273	375	0.0%	Shares	Sole	2024-10-29
2024-06-30	$7,740	375	+1.9%	Shares	Sole	2024-07-31
2024-03-31	$9,115	368	-4.2%	Shares	Sole	2024-05-14
2023-12-31	$13,954	384	+1376.9%	Shares	Sole	2024-02-15
2023-09-30	$1,254	26	0.0%	Shares	Sole	2023-11-14
2023-06-30	$1,775	26	+44.4%	Shares	Sole	2024-05-14
2023-03-31	$872	18	0.0%	Shares	Sole	2024-05-14
2022-12-31	$1,084	18	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.